Halozyme Therapeutics Inc logo

Halozyme Therapeutics Inc

FRA:RV7 (USA)   Ordinary Shares
€ 53.08 (-5.52%) Sep 20
22.97
P/B:
25.91
Market Cap:
€ 6.73B ($ 7.51B)
Enterprise V:
€ 7.60B ($ 8.48B)
Volume:
150.00
Avg Vol (2M):
233.00
Trade In:

Halozyme Therapeutics Inc Valuation Measures